Log In
Print
BCIQ
Print
Print this Print this
 

Seebri Breezhaler, glycopyrronium bromide (NVA237) (formerly AD 237)

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionInhaled long-acting muscarinic antagonist (LAMA)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Latest Stage of DevelopmentRegistration
IndicationChronic obstructive pulmonary disease (COPD)
Partner

Novartis AG; Vectura Group plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today